Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies

NeuroImage: Clinical

Volumn 6, Issue , 2014, Pages 166-170

  Nakamura, Kunio ^a   Brown, Robert A ^a   Araujo, David ^a   Narayanan, Sridar ^a   Arnold, Douglas L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Brain volumetry; Brain water content; T2 relaxation time

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN LEVEL; BRAIN MAPPING; BRAIN SIZE; BRAIN TISSUE; BRAIN VOLUME CHANGE; BRAIN WATER; DEHYDRATION; FEMALE; HUMAN; NERVOUS SYSTEM PARAMETERS; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PSEUDO T2 RELAXATION TIME; REHYDRATION; RELAXATION TIME; WHITE MATTER; ATROPHY; BRAIN; FLUID THERAPY; LEISURE; MALE; METABOLISM; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TIME;

ADULT; ATROPHY; BRAIN; DEHYDRATION; FEMALE; FLUID THERAPY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; RELAXATION; TIME FACTORS;

EID: 84907519439     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2014.08.014     Document Type: Article

References (37)

1. Alzheimer A., Stelzmann R.A., Schnitzlein H.N., and Murtagh F.R. An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde" Clinical Anatomy (New York, N.Y.) 8 1995 429 431 10.1002/ca.980080612 8713166
2. Arnold D.L., and De Stefano N. Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): commentary Multiple Sclerosis (Houndmills, Basingstoke, England) 19 2013 1007 1008 10.1177/1352458513490550 23818020
3. Avants B.B., Epstein C.L., Grossman M., and Gee J.C. Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain Medical Image Analysis 12 2008 26 41 10.1016/j.media.2007.06.004 17659998
4. Bates, D., Maechler, M., (2009). Ime4: linear mixed-effects models using S4 classes R package version 0.999375-32
5. Caramanos Z., Fonov V.S., Francis S.J., Narayanan S., Pike G.B., Collins D.L., and Arnold D.L. Gradient distortions in MRI: characterizing and correcting for their effects on SIENA-generated measures of brain volume change Neuroimage 49 2010 1601 1611 10.1016/j.neuroimage.2009.08.008 19682586
6. Chen J.T., Collins D.L., Atkins H.L., Freedman M.S., Galal A., Arnold D.L. Canadian MSBMT Study Group Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis Neurology 66 2006 1935 1937 10.1212/01.wnl.0000219816.44094.f8 16801665
7. Collins D.L., Neelin P., Peters T.M., and Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space Journal of Computer Assisted Tomography 18 1994 192 205 10.1097/00004728-199403000-00005 8126267
8. Dawson J. The histology of multiple sclerosis Transactions, Royal Society of Edinburgh 50 1916 517 740
9. Derakhshan M., Narayanan S., Chen J.T., Giacomini P.S., Arnold D.L., and Collins D.L. Pseudo-T2 relaxation times using a dual turbo spin-echo sequence: methodology and validation 16th Annual Meeting of the Organization for Human Brain Mapping 2010
10. Duncan J.S., Bartlett P., and Barker G.J. Technique for measuring hippocampal T2 relaxation time AJNR. American Journal of Neuroradiology 17 1996 1805 1810 8933861
11. Duning T., Kloska S., Steinsträter O., Kugel H., Heindel W., and Knecht S. Dehydration confounds the assessment of brain atrophy Neurology 64 2005 548 550 10.1212/01.WNL.0000150542.16969.CC 15699394
12. Fisher E., Lee J.C., Nakamura K., and Rudick R.A. Gray matter atrophy in multiple sclerosis: a longitudinal study Annals of Neurology 64 2008 255 265 10.1002/ana.21436 18661561
13. Fisher E., Rudick R., Dalton C.M., MacManus D., Miller D.H., Lucas N., Hulme A., and Panzara M. The kinetics of brain atrophy during the first year of treatment with natalizumab 23rd Congress of the European Committee for the Treatment and Research in Multiple sclerosis, Prague, Czech Republic 2007
14. Fonov V.S., Janke A., Caramanos Z., Arnold D.L., Narayanan S., Pike G.B., and Collins D.L. Improved precision in the measurement of longitudinal global and regional volumetric changes via a novel MRI gradient distortion characterization and correction technique Lecture Notes in Computer Science 6326 2010 324 333 10.1007/978-3-642-15699-1-34
15. Fotenos A.F., Snyder A.Z., Girton L.E., Morris J.C., and Buckner R.L. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD Neurology 64 2005 1032 1039 10.1212/01.WNL.0000154530.72969.11 15781822
16. Jenkinson M., Bannister P., Brady M., and Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images Neuroimage 17 2002 825 841 10.1006/nimg.2002.1132 12377157
17. Kuznetsova, A., Brockhoff, P.B., (2012). MixMod: analysis of mixed models. R package version 1
18. Miller D.H., Soon D., Fernando K.T., MacManus D.G., Barker G.J., Yousry T.A., Fisher E., O'Connor P.W., Phillips J.T., Polman C.H., Kappos L., Hutchinson M., Havrdova E., Lublin F.D., Giovannoni G., Wajgt A., Rudick R., Lynn F., Panzara M.A., Sandrock A.W. Affirm Investigators MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS Neurology 68 2007 1390 1401 10.1212/01.wnl.0000260064.77700.fd 17452584
19. Molyneux P.D., Kappos L., Polman C., Pozzilli C., Barkhof F., Filippi M., Yousry T., Hahn D., Wagner K., and Ghazi M. The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon Beta-1b in Secondary Progressive Multiple Sclerosis Brain: A Journal of Neurology 123 Pt 11 2000 2256 2263 10.1093/brain/123.11.2256 11050025
20. Nakagawa S., and Schielzeth H. A general and simple method for obtaining R2 from generalized linear mixed-effects models Methods in Ecology and Evolution 4 2013 133 142 10.1111/j.2041-210x.2012.00261.x
21. Nakamura K., Guizard N., Fonov V.S., Narayanan S., Collins D.L., and Arnold D.L. Pairwise Jacobian integration method to measure grey matter atrophy in multiple sclerosis International Society for Magnetic Resonance in Medicine Workshop on Multiple Sclerosis as a Whole-Brain Disease 2013
22. Nakamura K., Guizard N., Fonov V.S., Narayanan S., Collins D.L., and Arnold D.L. Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis NeuroImage. Clinical 4 2014 10 17 10.1016/j.nicl.2013.10.015 24266007
23. Nakamura K., Rudick R.A., Lee J.C., Foulds P., and Fisher E. Effect of Intramuscular Interferon Beta-1a on Gray Matter Atrophy in Relapsing-Remitting Multiple Sclerosis 2010 American Academy of Neurology (AAN) Toronto, Ontario, Canada
24. Okujava M., Schulz R., Ebner A., and Woermann F.G. Measurement of temporal lobe T2 relaxation times using a routine diagnostic MR imaging protocol in epilepsy Epilepsy Research 48 2002 131 142 10.1016/S0920-1211(01)00325-4 11823117
25. R-Team R: A Language and Environment for Statistical Computing 2012 R Foundation for Statistical Computing Vienna, Austria 2007. ISBN 3-900051-07-0
26. Rajagopalan V., Lowe M.J., Beall E.B., Yue G.H., and Pioro E.P. T2 relaxometry measurements in low spatial frequency brain regions differ between fast spin-echo and multiple-echo spin-echo sequences Magma (New York, N.Y.) 26 2013 443 450 10.1007/s10334-012-0364-1 23354513
27. Rudick R.A., Fisher E., Lee J.-C., Simon J., and Jacobs L. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group Neurology 53 1999 1698 10.1212/WNL.53.8.1698 10563615
28. Sampat M.P., Healy B.C., Meier D.S., Dell'Oglio E., Liguori M., and Guttmann C.R. Disease modeling in multiple sclerosis: assessment and quantification of sources of variability in brain parenchymal fraction measurements Neuroimage 52 2010 1367 1373 10.1016/j.neuroimage.2010.03.075 20362675
29. Scahill R.I., Frost C., Jenkins R., Whitwell J.L., Rossor M.N., and Fox N.C. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging Archives of Neurology 60 2003 989 994 10.1001/archneur.60.7.989 12873856
30. Sled J.G., Zijdenbos A.P., and Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data IEEE Transactions on Medical Imaging 17 1998 87 97 10.1109/42.668698
31. Smith S.M. Fast robust automated brain extraction Human Brain Mapping 17 2002 143 155 10.1002/hbm.10062 12391568
32. Sormani M.P., Arnold D.L., and De Stefano N. Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis Annals of Neurology 75 2014 43 49 10.1002/ana.24018 24006277
33. Streitbürger D.-P., Möller H.E., Tittgemeyer M., Hund-Georgiadis M., Schroeter M.L., and Mueller K. Investigating structural brain changes of dehydration using voxel-based morphometry PloS One 7 2012 e44195 10.1371/journal.pone.0044195 22952926
34. Townsend T.N., Bernasconi N., Pike G.B., and Bernasconi A. Quantitative analysis of temporal lobe white matter T2 relaxation time in temporal lobe epilepsy Neuroimage 23 2004 318 324 10.1016/j.neuroimage.2004.06.009 15325379
35. Whittall K.P., MacKay A.L., Graeb D.A., Nugent R.A., Li D.K., and Paty D.W. In vivo measurement of T2 distributions and water contents in normal human brain Magnetic Resonance in Medicine: Official Journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine 37 1997 34 43 10.1002/mrm.1910370107 8978630
36. Zhang Y., Brady M., and Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm IEEE Transactions on Medical Imaging 20 2001 45 57 10.1109/42.906424 11293691
37. Zivadinov R., Reder A.T., Filippi M., Minagar A., Stüve O., Lassmann H., Racke M.K., Dwyer M.G., Frohman E.M., and Khan O. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis Neurology 71 2008 136 144 10.1212/01.wnl.0000316810.01120.05 18606968